Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

X4 Pharmaceuticals (XFOR) Return on Invested Capital (2020 - 2025)

X4 Pharmaceuticals (XFOR) has disclosed Return on Invested Capital for 6 consecutive years, with 0.92% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Invested Capital fell 75.0% year-over-year to 0.92%, compared with a TTM value of 0.92% through Sep 2025, down 75.0%, and an annual FY2024 reading of 0.36%, up 65.0% over the prior year.
  • Return on Invested Capital was 0.92% for Q3 2025 at X4 Pharmaceuticals, up from 1.2% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.09% in Q1 2025 and bottomed at 1.43% in Q1 2024.
  • Average Return on Invested Capital over 5 years is 0.8%, with a median of 0.92% recorded in 2025.
  • Peak annual rise in Return on Invested Capital hit 134bps in 2025, while the deepest fall reached -104bps in 2025.
  • Year by year, Return on Invested Capital stood at 0.86% in 2021, then fell by -1bps to 0.87% in 2022, then dropped by -8bps to 0.94% in 2023, then skyrocketed by 66bps to 0.32% in 2024, then plummeted by -191bps to 0.92% in 2025.
  • Business Quant data shows Return on Invested Capital for XFOR at 0.92% in Q3 2025, 1.2% in Q2 2025, and 0.09% in Q1 2025.